Shared-link access · Not indexed
PT-141 (Bremelanotide) Dosing Calculator
A step-by-step calculator for reconstitution volumes, syringe draw, and protocol reference. Educational use only — all dosing decisions require a licensed medical provider.
Read full PT-141 (Bremelanotide) profile →1
Peptide2
Vial Setup3
Regimen4
CardPT-141 (Bremelanotide)
Also known as: Bremelanotide, Vyleesi
Clinical / FDA-approved — Protocol evidence level
FDA-approved (Vyleesi 1.75 mg SC) for hypoactive sexual desire disorder (HSDD) in premenopausal women. Off-label use in men is community-documented.
Last reviewed: 2024-06-01
Contraindications — Do not use if:
- •Cardiovascular disease — transient BP increase observed
- •Concurrent use of naltrexone or other opioid antagonists (may reduce effect)
- •Uncontrolled hypertension
- •Pregnancy / breastfeeding